'The cure for low prices is typically low prices:' An investment chief overseeing $45 billion breaks down why current asset price pullbacks and investor skepticism is 'healthy' for the market — and shares 12 recession-proof stocks
businessinsider.com
news
2022-06-04 10:30:00

Stocks have fared poorly in 2022, but unlike other investors, Matthew Benkendorf isn't worried.In fact, Benkendorf — who oversees $45 billion in assets as the Chief Investment Officer of Vontobel's Quality Growth Boutique — believes that not only is the current stock downturn amidst sky-high inflation a natural result of the world's post-COVID normalization, but that it's also healthy for the market."A lot of the selloff is reasonable and expected in these frothy areas of the market. I think you're seeing this compounded by the effect that you had, over the last couple of years, a lot of abnormality and market behavior too," Benkendorf told Insider.
